Safety profile of trifluridine/tipiracil monotherapy in clinical practice: results of the German compassionate-use program for patients with metastatic colorectal cancer

Safety profile of trifluridine/tipiracil monotherapy in clinical practice: results of the German compassionate-use program for patients with metastatic colorectal cancer

Abstract Background Trifluridine/tipiracil (TAS-102, Lonsurf®), a novel oral anti-tumor agent combining an anti-neoplastic thymidine-based nucleoside analogue (trifluridine, FTD) with a thymidine phosphorylase inhibitor (tipiracil hydrochloride, TPI) presents a new treatment option for metastatic co...

Full description

Bibliographic Details
Main Authors: Stefan Kasper, Jens Kisro, Martin Fuchs, Christian Müller, Armin Schulz-Abelius, Meinolf Karthaus, Mohammad-Reza Rafiyan, Alexander Stein
Format: Article
Language:English
Published: BMC 2018-11-01
Series:BMC Cancer
Subjects:
Metastatic colorectal carcinoma
Trifluridine/tipiracil
TAS-102
Real world oncology
Online Access:http://link.springer.com/article/10.1186/s12885-018-5063-5

Internet

http://link.springer.com/article/10.1186/s12885-018-5063-5

Similar Items